My research currently explores the mechanisms underlying the effects of rapid-acting antidepressants, with a particular emphasis on the role of sex steroid hormones and their receptors in mood regulation, as well as their interaction with antidepressants.
I am also investigating the biological basis of excessive synaptic pruning observed in schizophrenia, focusing on the involvement of glial cells, the synaptic tagging machinery, and the roles sex steroid hormones play in this phenomenon.
Additionally, I am interested in understanding how second-generation antipsychotics lead to metabolic syndrome and in identifying cellular pathways that could be targeted to alleviate this constellation of side effects.
I have experience teaching and developing coursework in psychopharmacology, biopharmaceuticals and pharmacokinetics, as well as medicinal and pharmaceutical chemistry, with a focus on integrating theoretical knowledge with clinical and experimental applications. In addition to classroom teaching, I have actively supervised both master's and PhD students, supporting their research training and academic development across interdisciplinary projects.
